Variant · Snv
YTHDC2 NM_022828.5(YTHDC2):c.1689-3C>T
CI-VAR-00338829Explore in graph →NM_022828.5:c.1689-3C>TClinVar 3060266 rs72805421
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 3060266 | Benign | no assertion criteria provided | 0 | YTHDC2-related disorder; Chronic lymphocytic leukemia/small lymphocytic lymphoma; Lymphoma; Hepatocellular carcinoma; Uterine carcinosarcoma; Ovarian cancer; Familial pancreatic carcinoma; Malignant lymphoma, large B-cell, diffuse; Colorectal cancer; Gastric cancer | germline | 2 | Jan 10, 2020 | clinvar |